The analyses and visuals on this site are for informational purposes only and do not constitute investment advice.

© 2026 Datafin Financial Data Analysis Systems. All rights reserved. · v2.0

Privacy PolicyTerms of UseCookie Policy

IRMD FINANCIAL STATEMENTS

Iradimed Co — balance sheet, income statement and cash flow trends

IRMDIradimed Co

🇺🇸 USA · NASDAQ · Healthcare · Medical Devices

Value itDuel
PriceFinancialsPeers

Income Statement

Quarterly progression — trailing-twelve-month values
RevenueNet Income to Owners
025 M50 M75 M202120222023202420252026

Profit Funnel

Q2 2026 · TTM
Revenue86.3 M $Gross Profit65.5 M $ · 76%Operating Income27.6 M $ · 32%Pre-tax Income29.7 M $ · 34%Net Income to Owners23.1 M $ · 27%

Percentages are relative to revenue.

Key Figures

YoY change
Revenue86.3 M $+11.2%
Gross Profit65.5 M $+9.6%
Operating Income27.6 M $+15.7%
EBITDA30.7 M $+12.8%
Net Income to Owners23.1 M $+11.6%

No peer data is available for this stock.

Balance Sheet

Quarterly period-end values
Total AssetsTotal LiabilitiesEquity
050 M100 M202120222023202420252026

Capital Structure

Q2 2026
Total Assets115 M
  • Equity101.7 M $88%
  • Current Liabilities9.2 M $8%
  • Long-term Liabilities4.1 M $4%

Key Figures

YoY change
Total Assets115 M $+8.0%
Total Liabilities13.2 M $+8.9%
Total Equity101.7 M $+7.9%
Cash & ST Investments59.1 M $+11.5%
Total Debt——
Net Debt-59.1 M $—

No peer data is available for this stock.

Cash Flow Statement

Quarterly progression — trailing-twelve-month values
Operating Cash FlowCapital ExpendituresFree Cash Flow
010 M20 M30 M202120222023202420252026

Cash Flow Bridge

Q2 2026 · TTM
010 M20 M27.1 M $Operating-2.6 M $Investing-18.5 M $Financing6.1 M $Net Change

Key Figures

YoY change
Operating Cash Flow27.1 M $-0.0%
Capital Expenditures2.2 M $-83.8%
Free Cash Flow24.9 M $+84.0%
Dividends Paid-15.8 M $-294.8%

No peer data is available for this stock.

Amounts are in the company’s reporting currency. Peer comparison tables use ratio-based metrics so currency differences do not distort the picture.

Go deeper on IRMD

Run a DCF valuation

Full DCF model with editable assumptions

Start a head-to-head duel

Compare two stocks metric by metric

Filter in the stock screener

Build your own universe with 400+ metrics

Data on this page refreshes once per day. Price data as of Sep 3, 26. This content is for informational purposes only and is not investment advice.